TP53 and hepatocellular carcinoma: A 2023 cross-sectional study of 41 surgically resected HCC cases revealed p53 expression in 35 patients (85.4%) of tumors (8 weak, 11 moderate, 16 strong expression) using nuclear staining thresholds ≥ 10% positivity [106].